Free Recommendation for Digest Readers

BUY Merck (MRK). But before you do, make sure you understand the full story and exactly what makes it a must-buy today................. [Stansberry Digest] Dear Reader, I have a 100% free recommendation to share with you today. It's [part of a big new prediction]( from our friend Joel Litman at Altimetry. Now, the biggest names on Wall Street have paid for Joel's work: BlackRock, Fidelity, Vanguard, and more than half the top 300 global money managers. His unique approach to the markets also lands him in Washington to consult with the FBI and the Department of Defense on a regular basis. And just last week, his system said to BUY Merck (MRK). But this is only part of [the story...]( Joel's system also just alerted him to an extremely rare moment in the history of the stock market. "The last time this happened, it could've handed you triple-digit gains like 722%, 196%, and 337% – all within a year. But Wall Street is making a big mistake ignoring this," he says. Joel's asked us to [spread the message]( with our readers. "Folks are going to get left behind if they don't understand what's coming right now," he added. [To see the full interview, read the transcript, and get the name of a streaming stock Joel says you should AVOID, click here.]( Regards, Brett AitkenPublisher, Stansberry Research P.S. Here's a picture Joel sent me after a lecture at the FBI... [The same type of data he presents to Washington is what he's sharing with you, 100% free today.]( More than twelve thousand Stansberry readers have already flocked to learn more about Joel's work. That's because he runs a type of analysis that none of our 30+ analysts are trained to do. It's led him to find gains for his clients of 1,359%, 490%, and 240%. [I'm confident you've never seen anything like this before.]( As Paul M. wrote: "I started following Joel just under a year ago, and I have closed out 10 positions for a 92% portfolio gain, including one, EXPI, in which I made an incredible 735% in just over six months... Joel is a stone-cold moneymaker!" Standard Disclaimer: The investment results described in these testimonials may not be typical; investing in securities carries a high degree of risk; you may lose some or all of the investment. [See what Joel's recommending today right here.]( Published by Stansberry Research. You have received this e-mail as part of your subscription to Stansberry Digest. If you no longer wish to receive special offers from Stansberry Digest, [click here](. You’re receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized investment advice. © 2023 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 [www.stansberryresearch.com](.